Figures & data
Figure 1. SMAC mimetics promote apoptosis in HIV-TCM via the autophagy-dependent formation of a CASP8-activating platform on phagophore membranes. Treatment of a heterogeneous population of uninfected and latent HIV-infected TCM with DIABLO/SMAC mimetics induces the degradation of XIAP and BIRC2. This triggers the induction of autophagy and the formation of a cell death complex consisting of pro-apoptotic (FADD, RIPK1, RIPK3, CASP8) and autophagy (ATG5, ATG7 and SQSTM1) proteins on unclosed autophagosomal/phagophore structures in HIV-TCM, but not uninfected TCM resulting in the selective apoptosis of only the infected HIV-TCM, while sparing uninfected bystander cells in the absence of viral activation.
![Figure 1. SMAC mimetics promote apoptosis in HIV-TCM via the autophagy-dependent formation of a CASP8-activating platform on phagophore membranes. Treatment of a heterogeneous population of uninfected and latent HIV-infected TCM with DIABLO/SMAC mimetics induces the degradation of XIAP and BIRC2. This triggers the induction of autophagy and the formation of a cell death complex consisting of pro-apoptotic (FADD, RIPK1, RIPK3, CASP8) and autophagy (ATG5, ATG7 and SQSTM1) proteins on unclosed autophagosomal/phagophore structures in HIV-TCM, but not uninfected TCM resulting in the selective apoptosis of only the infected HIV-TCM, while sparing uninfected bystander cells in the absence of viral activation.](/cms/asset/500e78dc-b990-414a-a51e-e5f12d870fbc/kaup_a_1569950_f0001_c.jpg)